OTTAWA, Feb. 4, 2016 /CNW/ -
The issue:
All lots of an authorized natural health product promoted for sexual enhancement, "Forta for Men", are being recalled after Health Canada testing confirmed one lot contains an undeclared drug: tadalafil. Tadalafil is a prescription drug that should only be used under the supervision of a health-care practitioner and may pose serious health risks.
Forta for Men is manufactured by Natural Performance Products Limited and the distributor, Vivo Brand Management Inc. of Cornwall, ON, is recalling all lots as a precautionary measure. The product is sold through retail stores across the country and online.
Products affected:
Forta for Men (NPN 80045132), available in packs of 2, 10 or 15 capsules.
Alternate names for the Forta for Men product include "Doctor's First for Men" and "Dr. First for Men".
Who is affected:
Consumers who have bought or used Forta for Men, particularly those with heart conditions.
What consumers should do
What Health Canada is doing:
Health Canada is monitoring the recall and following up with the distributor to determine the source of the undeclared drug.
Background:
Tadalafil should only be used under the supervision of a health-care practitioner. Products containing tadalafil or its analogs (very similar substances) should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure.
Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardiovascular side-effects if they use tadalafil and engage in sexual activity. Other possible side-effects of using tadalafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
How to report side effects to health products to Health Canada:
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada
PDF available at: http://stream1.newswire.ca/media/2016/02/04/20160204_C6813_PDF_EN_614228.pdf
Media Enquiries: Health Canada, (613) 957-2983; Public Enquiries: (613) 957-2991, 1-866 225-0709
Also from this source
Share this article